Telix Pharmaceuticals Limited Finance Costs
Telix Pharmaceuticals Limited (TLPPF) reported Finance Costs of $40.87 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-20.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:FinanceCosts · last filed 2026-02-20
AUD
| Period end | Finance Costs 12 month |
|---|---|
| 2024-12-31 | 36.94M AUD 20-F · filed 2025-02-24 |
| 2023-12-31 | 13.77M AUD 20-F · filed 2025-02-24 |
| 2022-12-31 | 6.69M AUD 20-F · filed 2025-02-24 |
USD
| Period end | Finance Costs 12 month |
|---|---|
| 2025-12-31 | $40.87M 20-F · filed 2026-02-20 |
| 2024-12-31 | $24.44M 20-F · filed 2026-02-20 |
| 2023-12-31 | $9.09M 20-F · filed 2026-02-20 |